Drug interactions
Immunoglobulin + Rozanolixizumab
Severity: Moderate
Immunoglobulin and Rozanolixizumab: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Immunoglobulin products compete for the neonatal Fc receptor, which rozanolixizumab blocks to lower IgG levels. Combined use may shift IgG kinetics and reduce rozanolixizumab effectiveness.
What this interaction means in plain words
Immunoglobulin and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Immunoglobulin belongs to Miscellaneous; Rozanolixizumab belongs to Miscellaneous.
Why it happens
Competition at the neonatal Fc receptor with pharmacodynamic opposition, since exogenous IgG supplies the IgG that rozanolixizumab removes.
What to do
Monitor clinical response closely. If long-term immunoglobulin therapy is essential, consider an alternative to rozanolixizumab.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Immunoglobulin and Rozanolixizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Rozanolixizumab
- Rozanolixizumab + Upadacitinib Major
- Abatacept + Rozanolixizumab Moderate
- Adalimumab + Rozanolixizumab Moderate
- Ado-trastuzumab + Rozanolixizumab Moderate
- Basiliximab + Rozanolixizumab Moderate
- Bevacizumab + Rozanolixizumab Moderate
Other interactions of Immunoglobulin
- Immunoglobulin + Pozelimab Major
- Dinutuximab beta + Immunoglobulin Moderate
- Efgartigimod alfa + Immunoglobulin Moderate
- Immunoglobulin + Nipocalimab Moderate
Frequently asked questions
Can I take Immunoglobulin with Rozanolixizumab?
MediHelp rates the interaction as moderate. Immunoglobulin and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Immunoglobulin products compete for the neonatal Fc receptor, which rozanolixizumab blocks to lower IgG levels. Combined use may shift IgG kinetics and reduce rozanolixizumab effectiveness.
How serious is the interaction between Immunoglobulin and Rozanolixizumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor clinical response closely. If long-term immunoglobulin therapy is essential, consider an alternative to rozanolixizumab.
What other medicines interact with Rozanolixizumab?
MediHelp also lists interactions of Rozanolixizumab with, for example, Upadacitinib, Abatacept, Adalimumab. The full list is on the Rozanolixizumab page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
